Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Christopher Brede"'
Autor:
Leslie Verville, Cassandra McKay, Tom Kouroukis, Suzanna Apostolovski, Mitchell Sabloff, Rena Buckstein, Kardi Kennedy, Karen Yee, Amanda Eakins, Christopher Bredeson
Publikováno v:
Current Oncology, Vol 31, Iss 8, Pp 4656-4674 (2024)
Acute leukemia is a rapidly progressive cancer of the blood and bone marrow that requires a high degree of complex, specialized, resource-intensive clinical and supportive care. The aging Canadian population has introduced an unprecedented demand on
Externí odkaz:
https://doaj.org/article/abcb2b5853a245e590c9b9d36eaa28ce
Publikováno v:
Journal of Urology. 206
INTRODUCTION AND OBJECTIVE:Paraneoplastic syndromes (PNS) associated with renal cell carcinoma (RCC) are signs and symptoms which cannot be directly attributed to primary tumor or metastasis. The p...
Autor:
Brian Lane, Silvia Mora, Ji Qi, Todd Morgan, Christopher Brede, James Peabody, Arvin George, null for the Michigan Urological Surgery Improvement Collaborativ
Publikováno v:
Journal of Urology. 203
INTRODUCTION AND OBJECTIVE:Guideline-recommended management of high risk (HR) prostate cancer (PCa) is radical prostatectomy with pelvic lymph node dissection (RP+PLND) or radiation therapy with/wi...
Publikováno v:
Current Oncology, Vol 30, Iss 4, Pp 4033-4040 (2023)
New therapies in a publicly funded healthcare system are first appraised by health technology assessment agencies that provide funding recommendations to the payers. Treatment with Chimeric Antigen Receptor-T cell (CAR-T) therapy is revolutionizing t
Externí odkaz:
https://doaj.org/article/360ae429adaa4df4b2033fa9acb35199
Autor:
Jeffrey S. Montgomery, Brian R. Lane, James E. Montie, Tae Kim, Ji Qi, Henry Peabody, Christopher Brede
Publikováno v:
Journal of Urology. 197
Publikováno v:
Journal of Urology. 183:585-589
In controlled trials medical expulsive therapy has improved outcomes in patients with ureteral stones but its real-world use and effectiveness outside a clinical trial have not been thoroughly examined. We studied the impact of targeted education of
Autor:
Adrian J. M. Bailey, Aidan M. Kirkham, Madeline Monaghan, Risa Shorr, C. Arianne Buchan, Christopher Bredeson, David S. Allan
Publikováno v:
Current Oncology, Vol 29, Iss 1, Pp 337-349 (2022)
The management of COVID-19 in hematopoietic cell transplant (HCT) recipients represents a special challenge given the variable states of immune dysregulation and altered vaccine efficacy in this population. A systematic search (Ovid Medline and Embas
Externí odkaz:
https://doaj.org/article/af052fb35dbb4edea79b31e784943966
Publikováno v:
Journal of Urology. 189
Autor:
Hero K. Hussain, David S. Morris, Cheryl T. Lee, Christopher Brede, Richard L. Prager, Paul E. Kazanjian
Publikováno v:
UroToday International Journal.
Autor:
Matthew Mei, Raju Pillai, Soyoung Kim, Noel Estrada-Merly, Michelle Afkhami, Lixin Yang, Zhuo Meng, Muhammad Bilal Abid, Mahmoud Aljurf, Ulrike Bacher, Amer Beitinjaneh, Christopher Bredeson, Jean-Yves Cahn, Jan Cerny, Edward Copelan, Corey Cutler, Zachariah DeFilipp, Miguel Angel Diaz Perez, Nosha Farhadfar, César O. Freytes, Shahinaz M. Gadalla, Siddhartha Ganguly, Robert Peter Gale, Usama Gergis, Michael R. Grunwald, Betty K. Hamilton, Shahrukh Hashmi, Gerhard C. Hildebrandt, Hillard M. Lazarus, Mark Litzow, Reinhold Munker, Hemant S. Murthy, Sunita Nathan, Taiga Nishihori, Sagar S. Patel, David Rizzieri, Sachiko Seo, Mithun Vinod Shah, Melhem Solh, Leo F. Verdonck, Ravi Vij, Ronald M. Sobecks, Betul Oran, Bart L. Scott, Wael Saber, Ryotaro Nakamura
Publikováno v:
Haematologica, Vol 108, Iss 1 (2022)
Somatic mutations are recognized as an important prognostic factor in chronic myelomonocytic leukemia (CMML). However, limited data are available regarding their impact on outcomes after allogeneic hematopoietic cell transplantation (HCT). In this re
Externí odkaz:
https://doaj.org/article/23076c7290164061a98b071548e28beb